Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 60

Tranexamic acid to reduce bleeding in sleeve gastrectomy and mini gastric bypass

Official title: Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery

Run by Patel Hospital, Pakistan · NCT07098780 · Data updated 2026-11-12

This trial will test whether giving tranexamic acid before laparoscopic sleeve gastrectomy or mini gastric bypass reduces bleeding in adults with morbid obesity.

More Hemorrhage trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment140 (estimated)
SponsorPatel Hospital, Pakistan
Academic / other
Locations1 site (Karachi, Sindh)
StatusRecruiting
StartedJune 12, 2023
Main results expectedJuly 31, 2025
Study endsAugust 31, 2025
Registry record updatedAugust 1, 2025
Trial IDNCT07098780 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18 years and older) with morbid obesity scheduled for laparoscopic sleeve gastrectomy or mini gastric bypass who are not taking anticoagulant or antiplatelet medications and have no bleeding disorder are ideal candidates.

Probably not a fit

Patients on antiplatelet or anticoagulant therapy, those with inherited or acquired bleeding disorders, or those with a known allergy to tranexamic acid would be excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, placebo-controlled Phase 4 trial comparing tranexamic acid given before surgery versus placebo in adults undergoing laparoscopic sleeve gastrectomy (LSG) or mini gastric bypass (MGB). Participants are randomized to receive either tranexamic acid or normal saline before their operation and then undergo standard perioperative care. Investigators will measure intraoperative blood loss, postoperative hemoglobin levels, and monitor for bleeding-related complications and other adverse events. The trial is conducted at a single site (Patel Hospital, Karachi) and excludes patients on anticoagulants, with bleeding disorders, or with known TXA allergy.

Why it matters

Potential benefit: If successful, tranexamic acid could reduce intraoperative and postoperative bleeding, lower transfusion needs, and decrease bleeding-related complications in bariatric surgery patients.

How similar studies have gone: Tranexamic acid has reduced surgical bleeding in many other specialties and some smaller bariatric studies suggest benefit, but large randomized evidence specifically in bariatric procedures is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients above 18 years of age AND
* Undergoing Laparoscopic Sleeve Gastrectomy and MGB
* Morbid obesity

Exclusion Criteria:

* Patients on anti-platelets/anti-coagulants
* Patients with inherited or acquired bleeding disorders
* Patients with any acute medical condition predisposing to bleeding
* Hormonal contraceptives
* Known Allery to TXA
* Female hormonal replacement therapy

Where it's running

  • Patel Hospital
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.